Skip to main navigation
Company Logo
  • About
    • About Overview
    • Leadership
    • Careers
  • Product
    • RECELL® System
  • Clinical Development
    • Pipeline/Clinical Trials
    • Patient Outcomes
    • Proof Assets
  • News & Media
  • Investor Relations
    • Overview
    • Press Releases
    • Events & Presentations
    • Financials
    • Annual Reports & Proxy
    • Stock Information
    • Corporate Governance
    • FAQ
    • Email Alerts
    • Contact
  • Contact
  • Search
  • Overview
  • Press Releases
  • Events & Presentations
  • Financials
  • Annual Reports & Proxy
  • Stock Information
  • Corporate Governance
  • FAQ
  • Email Alerts
  • Contact
/press-releases/news-releases
global

Investors: Press Releases

AVITA Medical Announces FDA 510(k) Clearance for Cohealyx, Expanding its Addressable Market
December 19, 2024
Learn More
AVITA Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference
December 18, 2024
Learn More
AVITA Medical to Present at the Piper Sandler 36ᵗʰ Annual Healthcare Conference
November 25, 2024
Learn More
  • News Releases
  • Announcements
December 19, 2024
AVITA Medical Announces FDA 510(k) Clearance for Cohealyx, Expanding its Addressable Market
December 18, 2024
AVITA Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference
November 25, 2024
AVITA Medical to Present at the Piper Sandler 36ᵗʰ Annual Healthcare Conference
November 12, 2024
AVITA Medical Announces Exclusive Distribution Agreement to Expand to Australia and New Zealand
November 8, 2024
AVITA Medical to Host Investor Webinar Briefing
November 7, 2024
AVITA Medical Reports Third Quarter Financial Results
October 10, 2024
AVITA Medical to Announce Third Quarter 2024 Financial Results
September 12, 2024
AVITA Medical to Present at 2024 Cantor Global Healthcare Conference
September 10, 2024
AVITA Medical to Participate in Lake Street’s 8th Annual Best Ideas Growth (BIG8) Conference
August 8, 2024
AVITA Medical to Host Investor Webinar Briefing
August 8, 2024
AVITA Medical Reports Second Quarter Financial Results
August 1, 2024
AVITA Medical Names Robin VanDenburgh as SVP of U.S. Commercial Sales
July 31, 2024
AVITA Medical Expands Portfolio with Unique Dermal Matrix to Advance Wound Care
July 11, 2024
AVITA Medical to Announce Second Quarter 2024 Financial Results
July 1, 2024
AVITA Medical Appoints Nicole Kelsey as Chief Legal and Compliance Officer, and Corporate Secretary
June 5, 2024
AVITA Medical Achieves Milestone with First Case Using RECELL GO
May 30, 2024
AVITA Medical Announces FDA Approval of RECELL GO
May 16, 2024
AVITA Medical to Host Investor Webinar Briefing
May 13, 2024
AVITA Medical Reports First Quarter Financial Results
April 15, 2024
AVITA Medical to Announce First Quarter 2024 Financial Results
Pagination
  • Current page 1
  • Page 2
  • Next page ›
  • Last page »
AVITA Medical, Inc. Logo with tag

Contact Investor Relations

Jessica Ekeberg
Director, Investor Relations
investor@avitamedical.com

Request Email Alerts
® 2024 AVITA Medical, Inc.
  • Terms of Use
  • Privacy Policy
  • CA Compliance
  • Social Media
  • CCPA
  • Compliance and Ethics
  • Important Safety Information

Social Media

  • Twitter (opens in new window)
  • Linkedin (opens in new window)